HealthPhoto: Hindustan TimesSupreme Court Criticizes Centre Over Expired Covid-era Drug Approvals
The Supreme Court reprimanded the Union government and the Drug Controller General of India for inaction against companies selling the antifungal drug Liposomal Amphotericin B under expired Covid-era emergency approvals. The court questioned regulatory officials on their five-year delay in addressing the issue, highlighting the drug's sale without clinical trials or proper oversight. Action was taken only after the court's intervention this year.
Hindustan Times·


